News

Mauna Kea Technologies Announces its 2025 Financial Calendar

14 January 2025

Paris and Boston, January 14, 2025 – 5:45 p.m. CET – Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE)
platform, today announces the publication of its 2025 Financial Calendar.

EventsDates*
Fourth Quarter 2024 SalesJanuary 15, 2025
Full-Year 2024 Financial ResultsApril 24, 2025
Annual General MeetingJune 5, 2025
Half-Year 2025 Financial ResultsOctober 2, 2025

*Subject to modification. Press releases are published after market closes.

READ THE FULL PRESS RELEASE

Latest News

Mauna Kea Technologies Announces Promising Results in New Application Combining Robotics and Cellvizio® for Precision Surgery in Head and Neck Cancers 

Mauna Kea Technologies Announces Promising Results in New Application Combining Robotics and Cellvizio® for Precision Surgery in Head and Neck Cancers 

Mauna Kea Technologies Secures Additional U.S. Artificial Intelligence Patent to Strengthen Endomicroscopy IP Complex 

Mauna Kea Technologies Secures Additional U.S. Artificial Intelligence Patent to Strengthen Endomicroscopy IP Complex 

Mauna Kea Technologies Reports Full Year 2024 Sales and Provides Strategic Update 

Mauna Kea Technologies Reports Full Year 2024 Sales and Provides Strategic Update